Cardlytics Q3 2022 Earnings Report
Key Takeaways
Cardlytics announced its Q3 2022 financial results, demonstrating a 12% year-over-year revenue increase to $72.7 million. The company reported a net income attributable to common stockholders of $6.3 million, or $0.19 per diluted share, compared to a net loss of $(44.5) million, or $(1.35) per diluted share in Q3 2021.
Revenue increased by 12% year-over-year to $72.7 million.
Billings increased by 12% year-over-year to $110.4 million.
Net income attributable to common stockholders was $6.3 million, or $0.19 per diluted share.
Cardlytics MAUs increased by 8% year-over-year to 184.7 million.
Cardlytics
Cardlytics
Forward Guidance
Cardlytics anticipates billings to be between $120.0 million and $132.0 million, revenue between $80.0 million and $90.0 million, and adjusted contribution between $38.0 million and $44.0 million for Q4 2022.